Afya Valuation Multiples

Afya is valued at $1.3B as of October 2026, a 2.2x revenue multiple. In the last 12 months, Afya revenue was $766M and Afya EBITDA was $331M.

See full Afya profile

Afya Overview

About Afya

Afya is a Brazilian provider of medical education and digital tools for physicians, listed on Nasdaq with a corporate base in Nova Lima. Its undergraduate business runs medical schools across more than 35 sites in Brazil, and it also sells continuing education, residency preparation courses and specialisation programmes. A practice-solutions segment offers clinical decision tools, practice management software and electronic prescriptions to doctors and patients. The group grew largely through acquisitions of medical schools and healthtech companies from 2018 onward and runs a corporate venture programme that invests in healthcare startups. Bertelsmann is its controlling shareholder, and the Esteves family founded the business. Its 2025 revenue was R$3,697.3 million, and in September 2026 it agreed to merge into YDUQS.


Founded

2019

HQ

Brazil

Employees

9.4K

Financials (LTM)

Revenue: $766M
EBITDA: $331M

EV

$1.7B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Afya Financials

Afya reported last 12-month revenue of $766M and EBITDA of $331M.

In the same LTM period, Afya generated $331M in EBITDA and $154M in net income.

Revenue (LTM)


Afya P&L

In the most recent fiscal year, Afya reported revenue of $730M and EBITDA of $293M.

Afya is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 40%, and net margin of 20%.

See analyst estimates for Afya
LTMLast FY202320242025202620272028
Revenue$766M$730M$563M$647M$730M
Gross Profit-$470M$346M$409M$470M
Gross Margin-64%61%63%64%
EBITDA$331M$293M$196M$249M$293M
EBITDA Margin43%40%35%39%40%
EBIT Margin33%33%27%31%33%
Net Profit$154M$149M$76M$124M$149M
Net Margin20%20%13%19%20%
Net Debt-$194M---

Financial data powered by Morningstar, Inc.

Afya Stock Performance

Afya has current market cap of $1.3B, and enterprise value of $1.7B.

Market Cap Evolution


Afya's stock price is $14.58.

Afya share price increased by 21.1% in the last 30 days, and by 2.6% in the last year.

Afya has an EPS (earnings per share) of $1.68.

See more trading valuation data for Afya
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.7B$1.3B0.4%21.1%2.2%2.6%$1.68

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Afya Valuation Multiples

Afya trades at 2.2x EV/Revenue multiple, and 5.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Afya

EV / Revenue (LTM)


Afya Financial Valuation Multiples

As of October 17, 2026, Afya has market cap of $1.3B and EV of $1.7B.

Afya has a P/E ratio of 8.4x.

LTMLast FY202320242025202620272028
EV/Revenue2.2x2.3x3.0x2.6x2.3x
EV/EBITDA5.2x5.8x8.7x6.8x5.8x
EV/EBIT6.8x7.1x11.3x8.6x7.1x
EV/Gross Profit-3.6x4.9x4.2x3.6x
P/E8.4x8.7x17.0x10.4x8.7x
EV/FCF7.7x11.7x16.8x11.6x11.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Afya Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Afya Margins & Growth Rates

Afya grew revenue by 7% and EBITDA by 14% in the last fiscal year.

In the most recent fiscal year, Afya reported gross margin of 64%, EBITDA margin of 40%, and net margin of 20%.

See estimated margins and future growth rates for Afya

Afya Margins

Last FY202420252026202720282029
Gross Margin64%63%64%64%
EBITDA Margin40%39%40%43%
EBIT Margin33%31%33%33%
Net Margin20%19%20%20%
FCF Margin20%23%20%29%

Afya Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%15%13%7%
Gross Profit Growth6%18%15%6%
EBITDA Growth14%28%18%14%
EBIT Growth7%32%21%7%
Net Profit Growth5%63%20%5%
FCF Growth56%45%(1%)56%

Data powered by FactSet, Inc. and Morningstar, Inc.

Afya Operational KPIs

Afya's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Afya's Rule of 40 is 50% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Afya's Rule of X is 61% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Afya
LTMLast FY202320242025202620272028
Rule of 4051%50%---
Bessemer Rule of X63%61%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue--35%--
Opex to Revenue-32%35%33%32%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Coursera$758M($49M)0.4x0.3x(6.6x)2.2x
National Company for Learning & Education$175M$66M9.0x7.6x23.9x20.9x
Cogna Educação$1.4B$461M1.6x1.4x4.7x4.7x
Universal Technical Institute$836M$141M1.6x1.5x9.4x13.0x
Cengage------
AcadeMedia$2B$438M1.3x1.2x5.7x5.4x
HUMANSOFT Holding$251M$133M3.3x3.5x6.3x7.3x
Emirates Mobility Company$210M$116M4.0x4.0x7.2x8.6x

This data is available for Pro users. Sign up to see all Afya competitors and their valuation data.

Start Free Trial

Afya VC Funding History

Before going public, Afya raised $311M in total equity funding, across 3 rounds.


Afya Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Mar-22SecondaryBertelsmann$161M-Bertelsmann agreed in March 2022 to acquire an additional six million Class B shares of Afya from the Esteves family, the company's founders, for US$161 million. The purchase took Bertelsmann to 57 percent of the voting rights in Afya, and the group said it planned to raise its stake further in the medium term, including through stock exchange purchases. Bertelsmann had entered Afya's capital in 2021 through the purchase of Crescera's stake and intended to consolidate the Brazilian business into its Bertelsmann Education Group. The shares were priced at US$26.90 each, according to Brazilian press at the time of the announcement. In fiscal 2021 Afya generated net revenue equivalent to around EUR 270 million and adjusted EBITDA of around EUR 118 million. Afya is a Nasdaq-listed Brazilian provider of medical education and digital solutions for physicians.
Jun-21Strategic investmentBertelsmann--Bertelsmann agreed to acquire a 25% capital interest and 46% of the voting rights in Afya for approximately €500 million in June 2021. The shares were purchased from Crescera Educacional II, a fund managed by Crescera Capital in which Bertelsmann was the anchor investor. The acquisition converted Bertelsmann's fund exposure into a substantial direct stake, alongside the Esteves founding family. Brazilian competition approval was obtained and the transaction closed in August 2021, giving Bertelsmann three of eleven board seats. Afya provides medical education and professional development through higher-education institutions, training programs and digital services. In 2020 it generated €203 million of revenue; at announcement it operated in 18 Brazilian states, served more than 220,000 monthly digital users and worked with 430 partner clinics and hospitals.
Apr-21Strategic investmentSoftBank Group$150M-The SoftBank Latin America Fund, a vehicle of SoftBank Group, announced a $150 million investment in Afya on 27 April 2021. The investment was made in Series A perpetual convertible preferred shares issued by the Nasdaq-listed Brazilian medical education company, and closed in early May 2021. In addition to the primary investment, SoftBank agreed to buy about 2.2 million existing Class A common shares from two current shareholders, and the fund and its affiliates were reported to own nearly 8.4 percent of Afya's stock on an as-converted basis. Afya said it intended to use the proceeds to fund future acquisitions and investments in complementary businesses, products and technologies. SoftBank had already backed Afya's iClinic acquisition in 2020. Afya provides medical education, continuing education, residency preparation and digital tools for medical practice in Brazil, and it was the country's largest provider of medical school seats at the time of the investment.

Acquisitions by Afya

Afya has acquired 29 companies to date.

Last acquisition by Afya was on May 13th 2025. Afya acquired Faculdade Única de Contagem for $17M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Afya

Faculdade Única de Contagem
Unidompedro
Sociedade Educacional e Cultural Sergipe DelRey
Glic
Description
Faculdade Única de Contagem is a Contagem, Brazil-based higher education institution offering medical, nursing, and health sciences programs with clinical training facilities. Part of the UniBH network since 2008, it enrolls 5,000 students annually in courses accredited by MEC, featuring simulation labs and partnerships with Hospital Mater Dei for internships. The campus spans 50,000 square meters with modern anatomy and research centers.
Unidompedro is an educational institution offering courses in higher education, science, arts, and culture in Pedro II, Brazil. It operates undergraduate programs in fields such as pedagogy, administration, law, and nursing alongside technical courses in agribusiness and informatics. The institution manages cultural events, scientific research initiatives, and community arts programs through partnerships with local universities and cultural centers.
Sociedade Educacional e Cultural Sergipe DelRey Ltda is the Brazilian company that operated the UNIT Alagoas university centre and the FITS Jaboatao dos Guararapes medical school in northeastern Brazil. The two schools had 340 medical seats between them when Afya bought the company in January 2023. They are private providers financed by tuition fees paid by students. Afya paid R$825 million for 100% of the company, about EUR 150 million, and completed the purchase in January 2023. The deal did not include the UNIT or FITS brand rights, which Afya could use for its first year, and it lifted Afya's total to 3,163 medical seats across 35 sites.
Glic is a Brazil-based web and mobile platform for glycemic control in diabetes management. It connects patients, caregivers, doctors, and nutritionists via electronic medical records for real-time data sharing and treatment decisions. The tool generates market indicators from user data across Brazilian regions.
HQ CountryBrazilBrazilBrazilBrazil
HQ City
Contagem
Salvador
Maceio
Barueri
Deal Date13 May 20252 May 20242 Jan 202323 May 2022
Valuation$17M$112Mundisclosed$4M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Afya acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Afya

Afya has invested in 5 companies to date.

Latest investment by Afya was on February 1st 2026. Afya invested in CareOn in their Strategic investment round.

See VC round multiples

Latest Investments by Afya

CareOn
Marisa.Care
Caveo
Lean Saude
Description
CareOn is a Brazilian healthtech company based in Belo Horizonte, Minas Gerais, founded in 2021. It runs a mobile application that connects doctors and other health professionals with hospitals, clinics and laboratories, handling shift and permanent job listings from posting through hiring. It also offers continuing education through CareOn Academy, which has more than 40,000 registered doctors. More than 100,000 jobs have been posted on the platform since its creation, about 6,000 of them in December 2025 alone. Revenue grew more than 160 percent from 2024 to 2025, and it serves large hospitals mainly in the Southeast. The company is a private business that earns commissions and fees from hospitals and clinics that use the app to fill shifts and positions. Afya's corporate venture programme, which backs seed and Series A healthtech startups, took a stake in 2026.
Marisa.Care is a São Paulo-headquartered AI platform optimizing hospital revenue cycles in Latin America through clinical gap detection and patient engagement. Deployed in facilities in Brazil and Mexico, its agents analyze electronic health records to trigger outreach via SMS and voice calls, achieving 30 percent uplift in procedure scheduling. The backend integrates with Epic and Cerner systems for predictive analytics on readmissions.
Caveo is a São Paulo-based financial platform designed for Brazilian physicians, offering automated income tracking, tax optimization, and investment portfolios. It aggregates earnings from multiple clinics and health plans, providing personalized savings plans compliant with Receita Federal regulations. Caveo serves over 10,000 doctors with tools for expense management and retirement planning, integrating with banks like Itaú and Nubank. Launched in 2021, the platform emphasizes secure data handling under LGPD standards.
Lean Saude is a Brazilian healthtech company based in Sao Paulo that applies data science and artificial intelligence to health management for insurers, self-managed health plans and large employers. It was founded in 2022 by doctors, with Eduardo Oliveira as chief executive. Its products cover data dashboards, prediction of high-risk patients and anomalous claims, standardised prior authorisation for surgeries and medical supplies, and monitoring of inpatient stays. The company says it manages more than 4.4 million lives. It is a private company with 51 to 200 employees, and it became the first investment of Afya's corporate venture capital programme in 2023. Lean Saude markets its platform as a way to make health management more efficient and cut costs for operators of corporate health plans. The company's investors include Afya, whose corporate venture programme backs seed and Series A healthtech startups with minority stakes.
HQ CountryBrazilBrazilBrazilBrazil
HQ City
Belo Horizonte
Belo Horizonte
São Paulo
Sao Paulo
Deal Date1 Feb 202620 Aug 202513 Jun 202415 May 2023
RoundStrategic investmentPre-seedSeedStrategic investment
Raisedundisclosed$2M$400Kundisclosed
InvestorsAfyaSérgio Ricardo Santos; Afya; Roberto Botelho; Paulo ChapchapAfyaAfya
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Afya investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Afya

When was Afya founded?Afya was founded in 2019.
Where is Afya headquartered?Afya is headquartered in Brazil.
How many employees does Afya have?As of today, Afya has over 9K employees.
Who is the CEO of Afya?Afya's CEO is Virgilio Deloy Capobianco Gibbon.
Is Afya publicly listed?Yes, Afya is a public company listed on Nasdaq.
What is the stock symbol of Afya?Afya trades under AFYA ticker.
When did Afya go public?Afya went public in 2019.
Who are competitors of Afya?Afya main competitors include Coursera, National Company for Learning & Education, Cogna Educação, Universal Technical Institute, Cengage, AcadeMedia, HUMANSOFT Holding, Emirates Mobility Company, Offcn Education Technology, American Public Education.
What is the current market cap of Afya?Afya's current market cap is $1.3B.
What is the current revenue of Afya?Afya's last 12 months revenue is $766M.
What is the current revenue growth of Afya?Afya revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Afya?Current revenue multiple of Afya is 2.2x.
What is the current EBITDA of Afya?Afya's last 12 months EBITDA is $331M.
What is Afya's EBITDA margin?Afya's last 12 months EBITDA margin is 43%.
What is the current EV/EBITDA multiple of Afya?Current EBITDA multiple of Afya is 5.2x.
What is the current FCF of Afya?Afya's last 12 months FCF is $222M.
What is Afya's FCF margin?Afya's last 12 months FCF margin is 29%.
What is the current EV/FCF multiple of Afya?Current FCF multiple of Afya is 7.7x.
How many companies Afya has acquired to date?As of October 2026, Afya has acquired 29 companies.
What was the largest acquisition by Afya?$134M acquisition of UNIGRANRIO on 27th May 2021 was the largest M&A Afya has done to date.
What companies Afya acquired?Afya acquired UNIGRANRIO, Unidompedro, SPES, FCMPB, Medcel, IESP, FASA, FESAR, UniRedentor, UniSL, and 19 other companies.
In how many companies Afya has invested to date?As of October 2026, Afya has invested in 5 companies.
What was the last Afya investment?On 1st February 2026 Afya invested in CareOn, participating in a Strategic investment round.
In what companies Afya invested in?Afya invested in Marisa.Care, Caveo, Faster, CareOn, and Lean Saude.

See public comps similar to Afya

Lists including Afya

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial